Dagfinn Steinar Øgreid
Keine laufenden Positionen mehr
Profil
Dagfinn Steinar Øgreid is the founder of ScreenCancer AS, which was founded in 2007.
He held the title of Oncology Director from 2009 to 2011.
He also worked as a Director at Novel Diagnostics AS.
Dr. Øgreid earned a doctorate degree from the University of Bergen.
Ehemalige bekannte Positionen von Dagfinn Steinar Øgreid
| Unternehmen | Position | Ende |
|---|---|---|
Novel Diagnostics AS
 Novel Diagnostics AS BiotechnologyHealth Technology Novel Diagnostics AS provides biomedical research and diagnostics development services. It sells and develops medical and diagnostic products and drives commercialization of research results. The firm also invests in securities; either in form of follow-up investments in companies already has invested in, or as part of other strategic investments. The company was founded on June 10, 2002 and is headquartered in Bergen, Norway. | Direktor/Vorstandsmitglied | - |
ScreenCancer AS
 ScreenCancer AS Medical/Nursing ServicesHealth Services ScreenCancer AS offers cancer screening and diagnostic program to the public. It provides a panel of screening tests for several major cancers such as colorectal, bladder, breast, prostate, skin, and lung. The company was founded by Christian Horn and Dagfinn Steinar Ogreid in 2007 and is headquartered in Sola, Norway. | Gründer | - |
Ausbildung von Dagfinn Steinar Øgreid
| University of Bergen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
ScreenCancer AS
ScreenCancer AS Medical/Nursing ServicesHealth Services ScreenCancer AS offers cancer screening and diagnostic program to the public. It provides a panel of screening tests for several major cancers such as colorectal, bladder, breast, prostate, skin, and lung. The company was founded by Christian Horn and Dagfinn Steinar Ogreid in 2007 and is headquartered in Sola, Norway. | Health Services |
Novel Diagnostics AS
Novel Diagnostics AS BiotechnologyHealth Technology Novel Diagnostics AS provides biomedical research and diagnostics development services. It sells and develops medical and diagnostic products and drives commercialization of research results. The firm also invests in securities; either in form of follow-up investments in companies already has invested in, or as part of other strategic investments. The company was founded on June 10, 2002 and is headquartered in Bergen, Norway. | Health Technology |
